全球經腸營養市場按產品、流程類型、階段、適應症、最終用途、銷售管道和地區分類

Global Enteral Feeding Formulas Market, By Product, By Flow Type, By Stage, By Indication, By End Use, By Sales Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球經腸營養市場規模估計為 69.4 億美元，預計到 2032 年將達到 131 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 9.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	69.4億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	9.50%	2032年價值預測	131億美元

經腸營養是將營養補充品直接注射到無法充分口服食物的患者的胃、十二指腸或空腸。經腸營養有很多種類型。蛋白質經腸營養適用於需要營養補充但碳水化合物或脂肪攝取量極少的人。標準經腸營養含有均衡的碳水化合物、蛋白質和脂肪。這些配方可滿足大多數日常營養需求，適合長期使用。疾病特異性配方是針對某些健康狀況（如糖尿病、腎衰竭和肝病）量身定做的。含纖維配方含有可溶性和不可溶性纖維，可促進正常的腸道功能。

每種類型都有其優缺點。以蛋白質為基礎的配方奶粉有助於滿足蛋白質需求，且不會攝取過多的熱量，但營養均衡性不足。標準配方奶粉提供均衡的營養，但可能無法滿足特殊的飲食需求。針對特異性疾病的配方奶粉可以滿足某些疾病的營養需求，但價格較高。含有膳食纖維的配方奶粉有助於規律排便，但口感更濃稠，熱量也更高。應根據個人健康狀況、營養需求和耐受性選擇合適的配方奶粉。經腸營養可為無法透過口服攝取的患者提供充足的營養。

市場動態：

全球經腸營養市場受到老齡人口成長、慢性病患病率上升、早產數量增加以及成人吞嚥困難急劇上升的驅動。根據聯合國的預測，到 2050 年，60 歲及以上老年人口將幾乎加倍，超過年輕人口。老年人更容易患上需要經腸營養支持的疾病，如失智症和術後併發症。此外，國際上需要經腸營養支持的癌症、神經系統疾病和胃腸道疾病等慢性疾病呈現上升趨勢。這對市場成長產生了積極影響。然而，替代餵食方法的可用性、與管相關的感染風險以及專門配方的高成本正在抑制市場成長。有機、非基因改造和無過敏原配方的開發為市場相關人員提供了有利可圖的機會。

本研究的主要特點

本研究報告對全球經腸營養市場進行了詳細分析，並以 2024 年為基準年，給出了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它揭示了各個領域的潛在收益成長機會，並解釋了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球經腸營養市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球經腸營養市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球經腸營養市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 6.94 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.50%	2032 Value Projection:	USD 13.1 Bn

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

Market Dynamics:

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study:

This report provides an in-depth analysis of the global enteral feeding formulas market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global enteral feeding formulas market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market

Global Enteral Feeding Formulas Market Detailed Segmentation:

By Product
- Standard Formula
- Disease-specific Formulas
- Elemental Formulas
- Specialized Formulas
By Flow Type
- Intermittent Feeding Flow
- Continuous Feeding Flow
By Stage
- Adults
- Pediatrics
By Indication
- Alzheimer's
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Others (Malabsorption/GI Disorder/Diarrhea, etc.)
By End Use
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
By Sales Channel
- Online Sales
- Retail Sales
- Institutional Sales
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Nestle
- VICTUS
- Primus Pharmaceuticals, Inc.
- Meiji Holdings. Co., Ltd.
- Mead Johnson & Company, LLC
- Abbott
- Danone S.A
- Fresenius Kabi AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Enteral Feeding Formulas Market, By Product
- Global Enteral Feeding Formulas Market, By Flow Type
- Global Enteral Feeding Formulas Market, By Stage
- Global Enteral Feeding Formulas Market, By Indication
- Global Enteral Feeding Formulas Market, By End User
- Global Enteral Feeding Formulas Market, By Sales Channel
- Global Enteral Feeding Formulas Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising incidence of chronic diseases
- Changes in healthcare landscape and reimbursement policies
- Increasing preference for homecare services
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Enteral Feeding Formulas Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Enteral Feeding Formulas Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Standard Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Disease-specific Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Elemental Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Specialized Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Enteral Feeding Formulas Market, By Flow Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intermittent Feeding Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Continuous Feeding Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Enteral Feeding Formulas Market, By Stage, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Enteral Feeding Formulas Market, By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Alzheimer's
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Nutrition Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cancer Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Chronic Kidney Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Orphan Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Dysphagia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Malabsorption/GI Disorder/Diarrhea, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Enteral Feeding Formulas Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cardiology
Neurology
Critical Care (ICU)
Oncology
Others
Home Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Global Enteral Feeding Formulas Market, By Sales Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Institutional Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

11. Global Enteral Feeding Formulas Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

12. Competitive Landscape

Nestle
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Strategies
VICTUS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Primus Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Meiji Holdings. Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mead Johnson & Company, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Danone S.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views